Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients: Safety of resuming heparin after disappearance of HIT antibodies

Nephron - Clinical Practice

Volumn 104, Issue 4, 2006, Pages

  Hartman, V ^a   Malbrain, M ^a   Daelemans, R ^a   Meersman, P ^a   Zachee P ^a  

^a ZNA Stuivenberg ^*  (Belgium)

Author keywords

Hemodialysis; Heparin induced thrombocytopenia; PF4 heparin antibodies

Indexed keywords

HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; CLINICAL FEATURE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; LUNG EMBOLISM; LUNG INSUFFICIENCY; MALE; NAUSEA; PALLOR; PRIORITY JOURNAL; PSEUDOPULMONARY EMBOLISM; SINGLE DRUG DOSE; SYMPTOMATOLOGY; TACHYPNEA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS; VERTIGO; WEAKNESS;

AGED; ANTICOAGULANTS; AUTOANTIBODIES; DRUG TOXICITY; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RENAL DIALYSIS; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

EID: 33845284214     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094959     Document Type: Article

References (20)

1. Warkentin TE, Greinacher A (eds): Heparin-Induced Thrombocytopenia, ed 3. New York, Dekker, 2004.
2. Popov D, Zarrabi MH, Foda H, Graber M: Pseudopulmonary embolism: acute respiratory distress in the syndrome of heparin-induced thrombocytopenia. Am J Kidney Dis 1997;29:449-452.
3. Kamper AM, Lins RL, Zachee P, Van Bergen S, Hosten S, Daelemans R: Safety of combining ticlopidine with nadroparin in the routine treatment of chronic hemodialysis patients. Nephron 1997;77:484-485.
4. Warkentin TE, Heddle NM: Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2003;2:148-157.
5. Warkentin TE: Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia: recommendation of the College of American Pathologists. Arch Pathol Lab Med 2002;126:1415-1423.
6. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG: Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-1708.
7. Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Meyer D: Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thombocytopenia. Br J Haematol 1996;92:945-949.
8. Reilly RF: Th e pathophysiology of immune-mediated heparin-induced thrombocytopenia. Semin Dial 2003;16:54-60.
9. Yamamoto S, Koide M, Matsuo M, Suzuki S, Ohtaka M, Saika S, Matsuo T: Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 1996;28:82-85.
10. Greinacher A, Zinn S, Wizemann S, Birk UW: Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis. Lancet 1996;348:764.
11. Sitter T, Spannagl M, Banas B, Schiff H: Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients. Nephron 1998;79:245-246.
12. Luzzatto G, Bertoli M, Cella G, Fabris F, Zaia B, Girolami A: Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. Thromb Res 1998;89:115-122.
13. Boon DM, van Vliet HH, Zietse R, Kappers-Klunne MC: The presence of antibodies against a PF4-heparin complex in patients on haemodialysis. Th romb Haemost 1996;76:480.
14. O'Shea SI, Sands JJ, Nudo SA, Ortel TL: Frequency of anti-heparin- platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis. Am J HematoI 2002;69:72-73.
15. O'Shea SI, Ortel TL, Kovalik EC: Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. Semin Dial 2003;16:61-67.
16. Tejedor Alonso MA, Lopez Revuelta K: Thrombocytopenia and anaphylaxis secondary to heparin in a hemodialysis patient. Clin Nephrol 2005;63:236-240.
17. Warkentin TE: An overview of the heparin-induced thrombocytopenia syndrome. Semin Thromb Hemost 2004;30:271-283.
18. Fretschner R, Dietrich K, Unertl K, Greinacher A: Management of liver transplantation in a patient with a history of heparin-induced thrombocytopenia. Transpl Int 2005;18:664-667.
19. Lee DH, Warkentin TE: Frequency of heparin-induced thrombocytopenia;in Warkentin, TE Greinacher A (eds): Heparin-Induced Thrombocytopenia, ed 2. New York, Dekker, 2001.
20. Potzsch B, Klovekorn WP, Madlener K: Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med 2000;343:173.